LBF16000PG01: Difference between revisions
No edit summary |
m LBF161nnPG01 moved to LBF16000PG01 |
(No difference)
| |
Revision as of 17:30, 16 December 2008
| IDs and Links | |
|---|---|
| LipidBank | XPR1421 |
| LipidMaps | LMFA03010136 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF16000PG01 |
| PROSTAGLANDIN E-MAJOR URINARY METABOLITE | |
|---|---|
| |
| Structural Information | |
| 8- [ 2 (R) - (2-Carboxyethyl) -5 (R) -hydroxy-3-oxocyclopentan-1 (R) -yl ] -6-oxooctanoic acid | |
| |
| Formula | C16H24O7 |
| Exact Mass | 328.152203122 |
| Average Mass | 328.35756000000003 |
| SMILES | OC(=O)CCCCC(=O)CC[C@@H]([C@H](O)1)[C@@H](CCC(O)=O)C(=O)C1 |
| Physicochemical Information | |
| ETHYL ACETATE HambergMet al. | |
| Spectral Information | |
| Mass Spectra | DIMETHYL ESTER DI-O-METHYLOXIME TMS ETHER DERIVATIVE ; m/e 486, 455, 369, 365, 355, 286, 279, 268, 265, 196, 115 HambergMet al. |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
